1-15 of 15
Norbert Frickhofen, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Time from Diagnosis to Treatment Does Not Affect Outcome in Intensively Treated Patients with Newly Diagnosed Acute Myeloid Leukemia

Christoph Röllig, MD MSC, Michael Kramer, M.Sc., Christoph Schliemann, Jan-Henrik Mikesch, MD, Björn Steffen, MD, Alwin Krämer, MD, Tim Sauer, MD, Mathias Hänel, MD, Regina Herbst, MD, Kerstin Schäfer-Eckart, MD, Richard Noppeney, MD, Edgar Jost, MD, Tim H Brümmendorf, MD, Stefan W Krause, MD, Volker Kunzmann, MD PhD, Hermann Einsele, MD, Sebastian Scholl, Andreas Hochhaus, MD, Lars R. Fransecky, MD, Martin Kaufmann, MD, Andreas Neubauer, MD, Dirk Niemann, MD, Markus Schaich, MD, Norbert Frickhofen, MD, Alexander Kiani, Frank Heits, MD, Ulrich Krümpelmann, Ulrich Kaiser, MD, Johannes Kullmer, Maxi Wass, MD, Stefan Klein, MD, Malte Von Bonin, Jan Moritz Middeke, MD, Christian Thiede, MD, Friedrich Stoelzel, MD, Johannes Schetelig, MDMSc, Gerhard Ehninger, MD, Claudia D Baldus, Carsten Müller-Tidow, MD, Uwe Platzbecker, Hubert Serve, MD, Martin Bornhäuser, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 13.
https://doi.org/10.1182/blood-2019-123717
Published: 2019
Journal Articles

Clinical Characteristics and Outcome in IDH1/2 Mutant AML Patients - Analysis of 3898 Newly Diagnosed Patients with Acute Myeloid Leukemia

Jan Moritz Middeke, MD, Christoph Rollig, MD MSC, Michael Kramer, M.Sc., Alwin Kramer, MD, Tilman Bochtler, MD, Sebastian Scholl, MD, Andreas Hochhaus, MD, Edgar Jost, MD, Tim H. Brümmendorf, MD, Ralph Naumann, MD, Björn Steffen, MD, Volker Kunzmann, MD PhD, Hermann Einsele, MD, Markus Schaich, MD, Andreas Burchert, MD, Andreas Neubauer, Kerstin Schäfer-Eckart, MD, Christoph Schliemann, MD, Stefan W Krause, MD, Regina Herbst, MD, Mathias Hänel, MD, Norbert Frickhofen, MD, Richard Noppeney, MD, Ulrich Kaiser, MD, Claudia D. Baldus, MD, Martin Kaufmann, MD, Zdenek Racil, MD, Sebastian Stasik, PhD, Katja Sockel, MD, Malte von Bonin, MD, Carsten Müller-Tidow, Uwe Platzbecker, Wolfgang E. Berdel, MD, Jiri Mayer, MD, Hubert Serve, MD, Gerhard Ehninger, MD, Johannes Schetelig, MD MSc, Christian Thiede, MD, Friedrich Stoelzel
Journal: Blood
Blood (2018) 132 (Supplement 1): 1461.
https://doi.org/10.1182/blood-2018-99-118128
Published: 2018
Journal Articles

EZH2 Mutations and Impact on Clinical Outcome Analyzed in 1604 Patients with Acute Myeloid Leukemia

Sebastian Stasik, PhD, Jan Moritz Middeke, MD, Michael Kramer, M.Sc., Christoph Rollig, MD MSC, Alwin Krämer, MD, Sebastian Scholl, MD, Andreas Hochhaus, MD, Martina Crysandt, Tim H. Brümmendorf, MD, Ralph Naumann, MD, Björn Steffen, MD, Volker Kunzmann, MD PhD, Hermann Einsele, MD, Markus Schaich, MD, Andreas Burchert, MD, Andreas Neubauer, Kerstin Schäfer-Eckart, MD, Christoph Schliemann, MD, Stefan W Krause, MD, Regina Herbst, MD, Mathias Hänel, MD, Norbert Frickhofen, MD, Richard Noppeney, MD, Ulrich Kaiser, MD, Claudia D. Baldus, MD, Martin Kaufmann, MD, Zdenek Racil, MD, Uwe Platzbecker, Wolfgang E. Berdel, MD, Jiri Mayer, MD, Hubert Serve, MD, Carsten Müller-Tidow, Gerhard Ehninger, MD, Martin Bornhäuser, Johannes Schetelig, MD, Christian Thiede, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 1528.
https://doi.org/10.1182/blood-2018-99-114421
Published: 2018
Journal Articles

The Addition of Sorafenib to Standard AML Treatment Results in a Substantial Reduction in Relapse Risk and Improved Survival. Updated Results from Long-Term Follow-up of the Randomized-Controlled Soraml Trial

Christoph Rollig, MD MSC, Hubert Serve, Andreas Hüttmann, MD, Richard Noppeney, MD, Carsten Müller-Tidow, Utz Krug, Claudia D. Baldus, MD, Christian H. Brandts, MD, Volker Kunzmann, MD PhD, Hermann Einsele, Alwin Krämer, MD, Kerstin Schäfer-Eckart, MD, Andreas Neubauer, MD, Andreas Burchert, MD, Aristoteles Giagounidis, MD, Stefan W. Krause, Andreas Mackensen, MD, Walter E. Aulitzky, MD, Regina Herbst, MD, Mathias Hänel, MD, Alexander Kiani, Norbert Frickhofen, MD, Johannes Kullmer, Ulrich Kaiser, MD, Hartmut Link, MD PhD, Thomas Geer, MD, Albrecht Reichle, MD, Christian Junghanss, MD, Roland Repp, MD, Frank Heits, MD, Heinz Albert Durk, Thomas Illmer, Martin Bornhäuser, MD, Markus Schaich, MD, Stefani Barbara Parmentier, MD, Martin Goerner, MD, Christian Thiede, MD, Malte von Bonin, MD, Johannes Schetelig, MD, Michael Kramer, M.Sc., Wolfgang E. Berdel, Gerhard Ehninger
Journal: Blood
Blood (2017) 130 (Supplement 1): 721.
https://doi.org/10.1182/blood.V130.Suppl_1.721.721
Published: 2017
Journal Articles

Hemophagocytic Lymphohistiocytosis in Adults (aHLH): Results from the German HLH Registry

Sebastian Birndt, Thomas Schenk, MD, Frank M. Brunkhorst, MD, Georg Maschmeyer, MD, Frank Rothmann, MD, Thomas Weber, MD, Markus Müller, MD, Jens P. Panse, MD, Roland Schroers, MD, Jan Braess, MD, Norbert Frickhofen, MD, Gritta Janka, MD PhD, Kai Lehmberg, MD, Andreas Hochhaus, MD, Thomas Ernst, MD, Paul La Rosée, MD
Journal: Blood
Blood (2016) 128 (22): 2523.
https://doi.org/10.1182/blood.V128.22.2523.2523
Published: 2016
Journal Articles

Azacitidine Followed By Intensive Induction/Consolidation Chemotherapy in Older Patients with Acute Myeloid Leukemia (AML): Results from the Randomized AML-AZA Trial of the Study Alliance Leukemias (SAL)

Carsten Müller-Tidow, MD, Petra Tschanter, MD, Utz Krug, MD, Stefanie Goellner, PhD, Christoph Röllig, MD, Christian Thiede, MD, Anja Koschmieder, Martin Dugas, PhD, Joachim Gerss, PhD, Trude Butterfaß-Bahloul, Ruth Wagner, Stefan W. Krause, MD, Ulrich Kaiser, Volker Kunzmann, MD, Björn Steffen, MD, Richard Noppeney, MD, Wolfgang Herr, MD, Claudia D Baldus, Norbert Schmitz, MD, Katharina Götze, Albrecht Reichle, Martin Kaufmann, MD, Andreas Neubauer, MD, Kerstin Schäfer-Eckart, MD, Mathias Hänel, MD, Rudolf Peceny, MD, Haack Bea, Lilly Meredith, Norbert Frickhofen, MD, Michael G Kiehl, MD, Aristoteles A.N. Giagounidis, MD PhD, Martin Görner, Roland Repp, MD, Ralph Naumann, MD, Hartmut Link, MDPhD, Alexander Kiani, MD, Steffen Koschmieder, MD, Tim H. Brümmendorf, MD, Hubert Serve, MD, Gerhard Ehninger, MD, Wolfgang E Berdel, MD
Journal: Blood
Blood (2014) 124 (21): 946.
https://doi.org/10.1182/blood.V124.21.946.946
Published: 2014
Journal Articles

Favorable Outcome in a Large Cohort of Prospectively Treated Adult Patients with T-Lymphoblastic Lymphoma (T-LBL) Despite Slowly Evolving Complete Remission Assessed By Conventional Radiography

Nicola Gökbuget, MD, Andrea Wolf, Matthias Stelljes, MD, Andreas Hüttmann, MD, Eike C. Buss, Andreas Viardot, Kalina Brandt, MD, Maike de Wit, MD, Norbert Frickhofen, MD, Maxim Kebenko, MD, Mustafa Kondakci, MD, Doris Kraemer, MD, Stefan Schwartz, MD, Hubert Serve, MD, Karsten Spiekermann, MD, Reingard Stuhlmann, MD, Albrecht Reichle, Dieter Hoelzer, MD
Journal: Blood
Blood (2014) 124 (21): 370.
https://doi.org/10.1182/blood.V124.21.370.370
Published: 2014
Journal Articles

Lenalidomide with Low-Dose Dexamethasone (Rd) Continuously Versus Rd Induction, Tandem MEL140 with Autologous Transplantation and Lenalidomide Maintenance: Planned Interim Analysis of a Prospective Randomized Trial in Patients 60-75 Years of Age with Multiple Myeloma

Christian Straka, MD, Kerstin Schaefer-Eckart, MD, Florian Bassermann, MD, Hansen Timon, MD, Bernd Hertenstein, MD, Christian Langer, MD, Hans Salwender, MD, Stefan Knop, MD, Monika Engelhardt, MD, Martin Kropff, MD, Wolf Roesler, MD, Thomas Decker, MD, Holger Hebart, MD, Norbert Frickhofen, MD, Albrecht Reichle, Christian Gerecke, MD, Bernd Metzner, Else Heidemann, MD, Tim H Brummendorf, MD, Juliane Ababei, MD, Wolfram E Jung, MD, Martin Gramatzki, MD, Marcus Hentrich, MD, Peter Bojko, MD, Ivana von Metzler, MD, Martin Kaufmann, MD, Ralph Naumann, MD, Thomas Kubin, MD, Burkhard Schmidt, MD, Jochem Walther, MD, Tobias Dechow, MD, Hannes Wandt, MD, Brigitte Schnabel, Axel Hinke, PhD, Hermann Einsele
Journal: Blood
Blood (2014) 124 (21): 3969.
https://doi.org/10.1182/blood.V124.21.3969.3969
Published: 2014
Journal Articles

Autologous Followed By Allogeneic Versus Tandem-Autologous Stem Cell Transplant in Newly Diagnosed FISH-del13q Myeloma

Stefan Knop, MD, Peter Liebisch, MD, Holger Hebart, MD, Ernst Holler, MD, Monika Engelhardt, MD, Bernd Metzner, MD, Dietrich Peest, MD, Walter Aulitzky, MD, Donald W. Bunjes, MD, Christian Straka, MD, Thomas Fischer, MD, Hannes Wandt, MD, Orhan Sezer, MD, Markus Hentrich, MD, Helmut Ostermann, MD, Christian Peschel, MD, Georg Hess, MD, Bernd Hertenstein, MD, Mathias Freund, MD, Martin H Kropff, MD, Hans-Heinrich Wolf, MD, Wolfram E Jung, MD, Norbert Frickhofen, MD, Ralf C. Bargou, Georg Maschmeyer, MD, Else Heidemann, MD, Christian Langer, MD, Lothar Kanz, MD, Christoph Meisner, PhD, Hermann Einsele, MD
Journal: Blood
Blood (2014) 124 (21): 43.
https://doi.org/10.1182/blood.V124.21.43.43
Published: 2014
Journal Articles

Prospective Randomized Trial of Len/Dex Induction Followed by Tandem MEL140 with Autologous Blood Stem Cell Transplantation and Len Maintenance Versus Continued Therapy with Len/Dex in Myeloma Patients Age 60–75 Years: Protocol-Defined Safety Analysis After 100 Patients

Christian Straka, Kerstin Schäfer-Eckart, Florian Bassermann, Bernd Hertenstein, Monika Engelhardt, Hans Salwender, MD, Wolf Rösler, Christian Langer, Georgia Schilling, Stefan Knop, Tim H Brümmendorf, Bernd Metzner, Holger Hebart, Albrecht Reichle, Norbert Frickhofen, MD, Else Heidemann, Juliana Ababei, Christian Gerecke, Wolfram Jung, Martin Gramatzki, Thomas Decker, Martin Kropff, MD, Ralph Naumann, Marcus Hentrich, Jochem Walther, Peter Bojko, Tobias Dechow, Hannes Wandt, Axel Hinke, Hermann Einsele
Journal: Blood
Blood (2012) 120 (21): 2012.
https://doi.org/10.1182/blood.V120.21.2012.2012
Published: 2012
Journal Articles

Moderate Intensive Chemotherapy Including CNS-Prophylaxis with Liposomal Cytarabine Is Feasible and effective in Older Patients with Ph-Negative Acute Lymphoblastic Leukemia (ALL): Results of a Prospective Trial From the German Multicenter Study Group for Adult ALL (GMALL)

Nicola Goekbuget, MD, Joachim Beck, MD, Monika Brueggemann, Thomas Burmeister, MD, Eike C. Buss, MD, Norbert Frickhofen, MD, Andreas Huettmann, MD, Anke Morgner, MD, Albrecht Reichle, Ingo Schmidt-Wolf, MD, Stefan Schwartz, MD, Hubert Serve, Prof. Dr. med., Bernd M Spriewald, MD, Michael Starck, MD, Matthias Stelljes, MD, Andreas Viardot, MD, Knut Wendelin, MD, Dieter Hoelzer, MD
Journal: Blood
Blood (2012) 120 (21): 1493.
https://doi.org/10.1182/blood.V120.21.1493.1493
Published: 2012
Journal Articles

Sequential High Dose Immuno-Chemotherapy Followed by Autologous Peripheral Blood Stem Cell Transplantation for Patients with Untreated Primary Central Nervous System Lymphoma - a Multicentre Study by the Collaborative PCNSL Study Group Freiburg

Gerald Illerhaus, MD, Kristina Fritsch, MD, Gerlinde Egerer, MD, Monika Lamprecht, MD, Nikolas von Bubnoff, MD, Hans-Heinrich Wolf, MD, Gottfried Dölken, MD, Stephan Stilgenbauer, MD, Jens Panse, MD, Stefan Balabanov, MD, PhD, Peter Hau, MD, Norbert Frickhofen, MD, Martin Bentz, MD, Alexander Roeth, MD, Robert Möhle, MD, Tobias Birnbaum, MD, Michael Pfreundschuh, MD, Claudia Hader, MD, Gabriele Ihorst, Martina Deckert, MD, Marco Prinz, MD, Elisabeth Schorb, MD, Heidi Fricker, Benjamin Kasenda, MD, Jürgen Finke, MD
Journal: Blood
Blood (2012) 120 (21): 302.
https://doi.org/10.1182/blood.V120.21.302.302
Published: 2012
Journal Articles

Allogeneic Stem Cell Transplant Versus Tandem High-Dose Melphalan for Front-Line Treatment of Deletion 13q14 Myeloma – An Interim Analysis of the German DSMM V Trial.

Stefan Knop, MD, Peter Liebisch, MD, Holger Hebart, Ernst Holler, PhD, Monika Engelhardt, Ralf C Bargou, MD, Bernd Metzner, Dietrich Peest, Walter E. Aulitzky, MD, Hannes Wandt, MD, Orhan Sezer, MD, PhD, Markus Hentrich, Helmut Ostermann, Christian Peschel, MD, Georg Hess, Bernd Hertenstein, Mathias Freund, MD, Martin H Kropff, Hans-Heinrich Wolf, Wolfram Jung, Norbert Frickhofen, MD, Georg Maschmeyer, Hans-Guenther Mergenthaler, Else Heidemann, Nicolaus Kröger, MD, Christian Straka, Corinna Engel, Lothar Kanz, Christoph Meisner, Hermann Einsele, MD
Journal: Blood
Blood (2009) 114 (22): 51.
https://doi.org/10.1182/blood.V114.22.51.51
Published: 2009
Journal Articles

The Effects of Induction Chemotherapy and High-Dose Melphalan with Tandem Autologous Transplantation in Multiple Myeloma: The Prospective Randomized DSMM 2 Study.

Christian Straka, MD, PhD, Peter Liebisch, MD, Burkhard Hennemann, MD, Bernd Metzner, MD, Hans Salwender, MD, Lothar Kanz, MD, PhD, Sigrid Adler-Reichel, MD, Wolf-Dieter Ludwig, MD, PhD, Hannes Wandt, MD, PhD, Martin Bentz, MD, PhD, Tim Bruemmendorf, MD, PhD, Markus Hentrich, MD, Lorenz Truemper, MD, PhD, Mathias Freund, MD, PhD, Hans-Heinrich Wolf, MD, Sezer Orhan, MD, PhD, Ralf Bargou, MD, PhD, Gottfried Doelken, MD, PhD, Norbert Schmitz, MD, PhD, Helga Bernhard, MD, PhD, Martin Gramatzki, MD, PhD, Norbert Frickhofen, MD, PhD, Helmut Ostermann, MD, PhD, Ralf Schmidmaier, MD, Stefan Ibach, PhD, Axel Hinke, PhD, Hermann Einsele, MD, PhD, Bertold Emmerich, MD, PhD
Journal: Blood
Blood (2007) 110 (11): 446.
https://doi.org/10.1182/blood.V110.11.446.446
Published: 2007
Journal Articles

Primary CNS Lymphoma - High-Dose-Chemotherapy with Autologous PBSCT and Hyperfractionated Radiotherapy as First-Line-Therapy - Results of a Multicenter Phase II Study.

Gerald Illerhaus, MD, Reinhard Marks, MD, Guenther Derigs, MD, Christan Peschel, MD, Norbert Frickhofen, MD, Roland Guttenberger, MD, Thomas Kubin, MD, Christoph B. Ostertag, MD, Juergen Finke, MD
Journal: Blood
Blood (2005) 106 (11): 680.
https://doi.org/10.1182/blood.V106.11.680.680
Published: 2005